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Abstract: Many suggested policy interventions for childhood and adolescent obesity have costs and
effects that fall outside the health care sector. These cross-sectorial costs and consequences have
implications for how economic evaluation is applied and although previous systematic reviews have
provided a summary of cost-effectiveness, very few have conducted a review of methods applied.
We undertook this comprehensive review of economic evaluations, appraising the methods used,
assessing the quality of the economic evaluations, and summarising cost-effectiveness. Nine electronic
databases were searched for full-economic evaluation studies published between January 2001 and
April 2017 with no language or country restrictions. 39 economic evaluation studies were reviewed
and quality assessed. Almost all the studies were from Western countries and methods were found to
vary by country, setting and type of intervention. The majority, particularly “behavioural and policy”
preventive interventions, were cost-effective, even cost-saving. Only four interventions were not
cost effective. This systematic review suggests that economic evaluation of obesity interventions is
an expanding area of research. However, methodological heterogeneity makes evidence synthesis
challenging. Whilst upstream interventions show promise, an expanded and consistent approach to
evaluate cost-effectiveness is needed to capture health and non-health costs and consequences.
Keywords: cost effectiveness; methods; children; adolescents; obesity; prevention; treatment
1. Introduction
Childhood obesity is a major global public health problem with associated health, social, and
emotional consequences, as well as long term direct and indirect costs [1–4]. Effective obesity
prevention and treatment in children and adolescents is therefore a priority as it is far more
cost-effective to prevent the onset of obesity in childhood compared to a lifetime of obesity-associated
costs. However, despite an increasing number of intervention studies, there are relatively few published
economic evaluations [5–7].
In many countries, the scarcity of public resources requires decision makers to seek information on
cost-effectiveness as well as clinical effectiveness in the knowledge that the use of resources in one way
prevents their use in others [8]. Economic evaluation is a means to aid decisions about public resource
allocation [9,10] and as obesity prevention and treatment often involves lifestyle interventions that have
costs and consequences that fall outside the health care sector, a societal perspective for evaluation
is usually recommended [10]. This means that all relevant resource use/costs and consequences
are measured, outlining how these fit within a given sector, such as health, education, or the wider
community [11]. However, when incorporating costs and outcomes that span across multiple sectors,
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it is not always clear how much society is willing to pay for a ‘non-health’ effect caused by an
intervention funded from a ‘health care budget’. Also, the valuation of resources for which no market
exists, such as informal care, or patient time costs, requires specific methods [8].
Seven recent reviews [12–18] have summarised the cost-effectiveness of obesity prevention and/or
treatment interventions in young people however none were designed to offer a rigorous review of
methods applied for economic evaluation. Five reviews had language restrictions [12–15,17] and
four excluded studies that were conducted in developing countries [12,13,15,17], limiting global
interpretation. Only two reviews appraised methods for handling inter-sectoral costs [13,17]. Just three
of the reviews used established criteria, e.g., Drummond checklist [19] to assess the quality of the
primary studies [13,14,17]. The search strategy was inadequate (e.g., search terms not fully reported) in
three reviews [12,15,18], and in the remaining four there were omissions of relevant databases, which
means that relevant studies could have been missed [13,14,16,17]. Furthermore, the most recent review,
which only focused on interventions in pre-school children, included studies reported up to November
2015 and, at least three new economic evaluation studies of childhood obesity interventions have been
published since then [20–22].
This paper reports on a systematic review of published economic evaluations of obesity prevention
and/or treatment interventions in children and adolescents (0–19 years) with the primary objective
of appraising the methods used and assessing the quality of the economic evaluations using the
Drummond checklist [19]. A secondary objective was to undertake a narrative synthesis of the
evidence of the cost-effectiveness.
2. Materials and Methods
The systematic review follows the reporting guidelines of Preferred Reporting Items for Systematic
Reviews and Meta-Analyses (PRISMA) [23] and a completed PRISMA checklist is presented in
Section A (see Supplementary Materials). The protocol is registered with the international prospective
register of systematic reviews (PROSPERO) database ref (CRD42017062236) and has previously been
published [24].
2.1. Literature Search
The following electronic health economics/biomedical databases were searched: MEDLINE
(Ovid); EMBASE (Ovid); Web of Science; CINAHL Plus; EconLit; PsycINFO; Cochrane Database
of Systematic Reviews (CDSR); Database of Abstracts of Reviews of Effects (DARE); the National
Health Service Economic Evaluation Database (NHS EED); Health Technology Assessment (HTA)
and Cost-Effectiveness Analysis (CEA) Registry. The following sources were also used to identify
potential additional studies: Google Scholar; relevant National Institute for Health and Care Excellence
(NICE) guidelines; the reference lists of eligible studies and review articles; and Grey literature such as
OpenSIGLE, National Obesity Observatory, NHS Evidence, National Technical Information Service,
Healthcare Management Information Consortium (HMIC), and RePEC (Economic Working papers)
database. The search was conducted in May 2017 and studies were sought between January 2001
and April 2017. The year 2001 was chosen since the first study evaluating the cost-effectiveness of
a childhood obesity treatment intervention was published then followed two years later by the first
economic evaluation of a childhood obesity prevention intervention [16]. Search strategies included
Medical Subject Headings (MeSH) terms and text words of key papers that were identified beforehand.
The search terms and text words were adapted for use within other bibliographic databases. The full
search strategy is presented in Section B (see Supplementary Materials).
2.2. Inclusion and Exclusion Criteria
Economic evaluations were included or excluded based on the following criteria:
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• Types of study: Primary full economic evaluations were included (studies in which both the
costs and outcomes of the alternatives are examined and in which a comparison of two or more
interventions or case alternatives are undertaken) including trial-based and model-based (using
trial data) evaluations. Partial economic evaluations; qualitative studies; conference abstracts;
and study protocols were excluded.
• Participants/population: Children and adolescents aged 0–19 years at the start of the intervention
and/or their parents/guardians were included. Family based interventions were also included
when the target participants were the children. Economic evaluations undertaken within
any country context were included. Interventions to tackle obesity due to a secondary cause
(e.g., Prader–Willi syndrome) were excluded.
• Intervention(s), exposure(s): All behavioural (focused on individual behaviour change
techniques), environmental (focused on modifying the local environment), or policy (focused
on population-wide legislative or fiscal action) interventions for the treatment or prevention of
overweight/obesity in children and/or adolescents were included. Pharmacological or surgical
interventions were excluded.
• Comparator(s)/control: Only studies with a clearly defined comparator were included with no
restrictions on the types of comparator(s).
• Outcome(s): No restrictions on outcomes measures. Potentially relevant outcomes were:
disability-adjusted life years (DALYs); quality-adjusted life years (QALYs); effectiveness outcomes
such as kilogramme weight loss; % body fat; body mass index (BMI) z-score; waist circumference;
overweight and obesity cases avoided; additional minute of moderate to vigorous physical activity
(MVPA); increase in overall physical activity level and metabolic equivalent (MET) hour gained.
Other criteria: There were no restrictions based on language.
2.3. Study Selection Procedure
The review followed a two-stage method. First, the main researcher and an independent researcher
individually screened titles and abstracts of identified publications against the selection criteria. If in
doubt, the full text version was requested. Second, full-text papers were reviewed by both researchers
and a final decision made with respect to the inclusion/exclusion criteria. There was 85% agreement
between the two reviewers. Any disagreements between the reviewers over the eligibility of specific
studies were resolved by discussion between all authors. To aid study selection and analysis of
non-English language articles, translation either in part or in whole was undertaken by academic
colleagues with the appropriate language skills. The literature search results were managed using
EndNote X7 (Thomson Reuters, Philadelphia, PA, USA).
2.4. Data Extraction
The study characteristics and findings were recorded using a standardised, pre-piloted
data extraction form (see Tables S1 (i)–S1 (iv) and Tables S2-4 (i)–S2-4 (iv) in Supplementary
Materials). This process was checked for completeness and accuracy by an independent researcher.
Any discrepancies between the reviewers over the data extraction process was identified and resolved
by discussion or by consensus with all authors.
2.5. Quality Assessment of Included Studies
The quality of the economic evaluations were judged against standard criteria (Drummond
checklist) [19], see Table S5 (see Supplementary Materials). Quality assessment of the included studies
was independently checked for completeness and accuracy by an independent researcher and any
discrepancies were resolved by discussion with all authors.
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3. Results
From the 4185 references initially identified, 39 economic evaluations were included—see Figure 1.
The most common reasons for exclusion were the lack of (full) economic evaluations, being a protocol
study, or including an ineligible target population.
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3.1. Details about Study Context
Full details about study context are presented in Tables S1 (i)–S1 (iv) (see Supplementary
Materials), and summarised in Table 1.
3.1.1. Interve tion and Comparator
Approximately half of the economic evaluations (23/39) were model-based [12,22,25–40]
compared to trial-based evaluations. A range of interventions were identified, all containing
individual behaviour change elements (Figure 2). A large proportion (25/39) (including all
treatment interventions) were focused exclusively on behaviour change techniques, the rest
combined individual behaviour change elements with either an environmental component
(modifying the local environment e.g., active school transport) [21,29–33,41,42] or a policy
component (population-wide legislative or fiscal interventions such as banning unhealthy
food advertising or a physical education policy) [25,27,28,35,38,43]. Approximately half of
the interventions (21/39; 12 prevention and 9 treatment) targeted a combination of physical
activity and dietary behaviours [12,20,26,32,36–42,44–50], the rest focused on either physical
activity [21,25,29–31,33,43,51–53] or dietary habits only [12,22,27,28,35,54].
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Table 1. Summary of general characteristics of the studies.
Study Characteristics Number of Studies Identified (%)
Year of publication
2001–2009 17 (44)
2010–2017 22 (56)
Study approach
Trial-based
Prevention 9 (23)
Treatment 7 (18)
Model-based
Prevention 19 (49)
Treatment 4 (10)
Comparator selected
Usual care 33 (85)
Another intervention 6 (15)
Country
High-income
Australia 15 (38.5)
New Zealand 2 (5)
The USA 12 (31.5)
Canada 1 (2.5)
The UK 4 (10)
Germany 2 (5)
Finland 1 (2.5)
Spain 1 (2.5)
Low and middle-income
China 1 (2.5)
Setting
Prevention
School 21 (54)
US/Australian state 5 (13)
Community 1 (2.5)
Home 1 (2.5)
Treatment
Clinical 9 (23)
School 1 (2.5)
Community 1 (2.5)
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The intensity of the interventions differed considerably. For prevention interventions, this ranged
from one session per three months [44] to approximately two sessions per month [51]; and for treatment
interventions, ranged from 1 [20] to 12 sessions per week [46]. The duration of the interventions also
differed, ranging from eight months [53] to four years [52] for prevention studies; and from three
months [20] to one year [46] for treatment studies. Overall therefore, the treatment interventions
were generally more intensive but delivered over a shorter time period compared to prevention
interventions. The comparison or control group was not always clearly specified but was assumed to
be ‘usual care’ in most of the studies (33/39) and often the studies did not justify their rationale for
choosing the comparator.
3.1.2. Country and Setting
The evaluations were spread across a wide range of countries and study settings. The
vast majority (38/39) originated from high-income countries, mainly Australasia (Australia
(n = 15) [12,21,28–32,40,44,50] and New Zealand (n = 2) [34,41]), with 13 from North America (USA
(n = 12) [22,25–27,35–38,42,43,46,49], Canada (n = 1) [47]) and 8 from Europe (UK (n = 4) [20,33,39,48],
Germany (n = 2) [51,52], Finland (n = 1) [54], Spain (n = 1) [53]). Only one study was from a developing
country context—China [45]. In terms of study setting, the majority of prevention interventions
(21/28) were school-based [21,22,26,29–32,34,36,37,41,42,45,49,51–53] and for treatment interventions,
most (9/11) took place in clinical settings [12,20,39,40,46–48,50,54].
3.2. Review of Economic Evaluation Methods
A detailed account of the economic evaluation methods are presented in Tables S2-4 (i)–S2-4 (iv)
(see Supplementary Materials).
3.2.1. Type of Economic Evaluation and Measures of Effectiveness
The majority of studies that conducted a cost-effectiveness analysis (CEA) used raw or
standardised BMI as a measure of clinical outcome (26/39) (18 prevention and 8 treatment), whilst
other studies used one or more measures from: cases of overweight/obesity prevented; unit increase
in MET minutes; reduction in body fat or waist circumference. Approximately half of the studies that
undertook a CEA also conducted a cost-utility analysis (CUA) [20,27–33,35,40] with QALYs as the
primary outcome measure. The review found that the vast majority of trial-based economic evaluations
(15/16) did not use QALYs/DALYs whereas most model-based evaluations (n = 20) tended to report
QALYs/DALYs as the primary economic outcome. When QALYs were used, the age of the participants
was between 6 and 11 years in the trial-based economic evaluation [20], and between 2 and 19 years in
the model-based economic evaluations.
A pattern with preferred type of economic evaluation by country context was apparent. Within
Australasia (13/17) a CUA or a combination of CUA and CEA [12,28–32,34,40] was most popular,
whereas the majority of studies from North America (7/13) [25,38,42,43,46,47,49], and the only study
from China [45] conducted a CEA only. Across Europe, only UK-based studies used CUA [20,33].
In terms of study setting, a CEA was most common in clinical settings (7/9), whereas within school
settings a mixed approach was applied with around half conducting a CEA (12/22). There was no
clear pattern found in terms of approach taken to evaluate prevention or treatment interventions.
3.2.2. Evaluation Perspective Taken
Most (35/39) studies clearly reported the study perspective. The majority (n = 29) were from a
societal perspective. Interestingly, none of the UK studies [20,33,39,48], compared to most of those
conducted within Australia and the USA, applied a societal perspective. Two studies reported using a
health care perspective, but from the data reported it was clear that wider societal costs were included
within a secondary analysis [20,50].
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For all interventions that included either a policy or environmental component (12/14),
the perspective was societal, whereas for interventions focused exclusively on individual behaviour
change a combination of societal (17/25) and healthcare (6/25) perspectives was undertaken.
A societal perspective was also adopted by the vast majority of interventions implemented in school
settings (19/22).
3.2.3. Time Horizon Considered and Type of Modelling Approach Taken
The time durations for the trial-based economic evaluations were predicted by the period of the
trial. Of interest this ranged from 8 months [53] to 6 years [52] in the prevention studies, and from
10 months [49] to 15 months [50] for the treatment interventions. For the model-based evaluations,
the time horizon was more at the analysts discretion and within this review ranged from at least
10 years (n = 5) [25,27,35,37,38] to a lifetime (15/23) [12,22,28–32,34,39,40]. The time horizon was
also found to be much shorter within clinical settings (6/9) [20,46–48,50,54] compared to the other
study settings such as schools for example. The majority of the studies did not justify their choice of
time horizon.
With respect to modelling, the vast majority of model-based studies (18/23) applied
Markov modelling [12,25,27–32,34,35,38–40] compared to decision analytic modelling [22,26,33,36,37].
The majority of the model-based studies did not justify their model choice and the description of
model details was suboptimal in most of them.
3.2.4. Choice of Discount Rate
For the majority of the trial-based studies (10/16) (4 prevention and 6 treatment), discounting
was not appropriate as the time horizons considered were relatively short (less than one
year) [20,42,45–49,51,53,54]. For all the trial-based studies of more than one year, all reported using a
discount rate in accordance with the relevant country guidelines apart from one prevention trial from
New Zealand [41], which used a 5% discount rate per year for costs, rather than the 3.5% discount rate
per year for both costs and outcomes recommended [55]. Most model-based studies (22/23) applied a
discount rate for both costs and outcomes (3% per year for Australia (n = 12) [12,28–32,40], the USA
(n = 8) [22,25–27,35–38] and the UK (n = 1) [39], and 3.5% per year for New Zealand (n = 1) [34].
Interestingly, the rates used for studies from Australia and the UK were not in accordance with
their respective country guidelines (which is 5% per year for Australia according to PBAC and 3.5%
per year for the UK according to NICE) [56,57]. However, different state governments in Australia
recommend different rates and the discount rate used in the included Australian and UK studies was
consistent with the US panel recommendations [58]. Most of the studies did not justify their choice of
discount rate.
3.2.5. Methods for Collecting and Estimating Resource Use/Costs
Half of the trial-based evaluations (8/16) (four prevention and four treatment) reported their
methods for collecting resource use [20,21,44,46,48,50–52], while only 10 out of 23 model-based
evaluations (nine prevention and one treatment) did so [22,25,27,29–32,35,38,40].
As expected, the choice of inclusion of a particular type of cost varied considerably according
to the study purpose, perspective, setting and the nature of the intervention being evaluated. Costs
tended to be categorised into programme delivery, direct medical (e.g., healthcare visits), direct
non-medical (e.g., travel time/cost for participants) and indirect (e.g., productivity losses because of
parents’ absence from work). In line with recommendations for CEA [59], the development/set up
costs were not considered in the vast majority of studies, apart from one trial-based prevention study
from the USA [43].
Of the nine studies (five prevention and four treatment) that included indirect costs incurred by
parents [20,29,30,32,40,42,46,50,52], these were mainly from Australia (n = 5) and most of them were
for preventive ‘behavioural’ interventions within a school-based setting (5/9). Also, direct non-medical
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costs were reported by four prevention studies from Australia [29,32,40,50] and one treatment study
from the USA [46]. Most of these types of costs (3/5) were for ‘behavioural’ interventions implemented
within a clinical setting.
3.2.6. Sensitivity Analysis Undertaken
The majority of the trial-based studies (10/16) conducted a deterministic sensitivity analysis to
assess the robustness of the results [20,21,41,42,44,50–54]. Most of the model-based studies (22/23)
apart from the study by Pringle et al. (2010) from the UK [33], conducted at least one type of sensitivity
analysis with the majority (n = 20) applying both deterministic and probabilistic sensitivity analysis in
line with recommendations. Half of these studies, however, did not justify the choice of covariates for
the sensitivity analysis.
3.3. Narrative Synthesis of Cost-Effectiveness Evidence
The most common method for presenting cost-effectiveness evidence was the incremental
cost-effectiveness ratio (ICER) (30/39). The vast majority of the studies (33/37), excluding the
CCA ones, reported results that were cost-effective. Some of these (13 of the model-based
prevention/treatment studies including 5 by Carter et al. (2009)), [12,27,28,33,35–39] illustrated cost
saving results. For instance, Long et al. (2015) concluded that a sugar-sweetened beverage excise tax
would increase benefits in terms of DALYs averted and result in healthcare cost savings in the USA [27].
Almost half of these 13 studies that illustrated cost-savings were from Australia, followed by 5 from the
USA and 2 from the UK. None of the trial-based evaluations reported cost saving results, probably due
to shorter time horizons. Whilst the findings are not directly comparable between studies due to the
heterogeneous nature of the methods used, all of the studies which evaluated interventions targeting
only dietary habits (8/8) and the majority of the studies targeting both physical activity and dietary
habits (19/21) indicated cost-effective or cost saving results. However, the studies which focused on
only physical activity indicated a proportionally smaller number of cost-effective or cost saving results
(7/10). Furthermore, the evidence suggests that the majority of behavioural interventions supported
by a policy intervention (4/6) were cost-saving [27,28,35,38].
A small number of studies (n = 4) [20,29–31] reported interventions to not be cost-effective.
The UK trial-based treatment study [20], which targeted a combination of physical activity and dietary
habits with the aim to reduce weight gain in children with obesity remained not cost-effective using
a CEA/CUA approach regardless of the choice of perspective. Also, the three model-based studies
that targeted only physical activity were not cost-effective, for example, the “Walking School Bus”
programme which had a high cost of delivery coupled with low participation rates [29].
3.4. Quality Assessment of the Included Studies
The quality of reporting the economic evaluations was assessed using the Drummond checklist.
Full details of the quality assessment are presented in Tables S6 (i)–S6 (iv) (see Supplementary
Materials). None of the included studies fulfilled all of the quality criteria however only a small
number of the studies were categorised as poor. One challenge regarding the quality assessment was
that quality was judged based on the published data only and there might be a difference in what has
been reported and what has actually been done. So a bad scoring study might just be due to lack of
transparency rather than lack of quality.
Certain criteria were simply not applicable to each respective study (e.g., items 12–15, due to
different perspectives chosen), while others were not reported. The three criteria which were least
well addressed were the rationale for the comparator, the justification for the choice of discount rate,
and the model choice. Whilst the time horizon for each study was generally well specified, most
studies omitted to provide reasons for choice. Additionally, approximately half of the studies did
not justify the choice of economic evaluation nor offered justification for what was explored within a
sensitivity analysis.
Int. J. Environ. Res. Public Health 2019, 16, 485 9 of 14
4. Discussion
To the best of our knowledge, this is the first study to conduct a review of the methods for economic
evaluation and to determine how these methods vary by setting, country, and intervention design.
The review identified some emerging patterns. We found that among the published economic
evaluations, there was no consistent measure of outcomes. Around half of the studies reported
clinical (e.g., BMI), rather than health-related outcome measures commonly used within economic
evaluation (QALYs/DALYs). This suggests that the measurement of QALYs/DALYs within obesity
trials is not firmly established. This heterogeneity of outcome measures will hinder comparability
of cost-effectiveness.
No evaluation applied a cost–benefit analysis (CBA) approach. Consideration of broader outcomes
going beyond the health sector allows for inclusion of costs and effects from multiple sectors and is
particularly relevant for obesity intervention. This is an emerging area of development within economic
evaluation and efforts are being made to adapt methodologies to promote the use of CBA [60]. These
approaches have been recommended by the UK Treasury guidance to evaluate (usually non-health)
public sector projects [61].
Model-based evaluations offer the opportunity to improve the generalisability of results as
they combine data from a variety of sources. However the findings from five of the model-based
evaluations identified within this review were based on small samples [22,26,33,36,37] and only one of
these offered data based on a lifetime horizon. Furthermore, all of the model-based evaluations were
for interventions that targeted individual health behaviours and were therefore highly dependent on
cultural, infrastructural and other system-related aspects. So the generalisability of results to other
contexts, particularly from developed to developing country settings, would be questionable [62].
The majority of the papers did not make explicit mention of procedures for checking their models
and no study assessed the sensitivity of their results to the choice of model-type. Despite associated
assumptions with modelling studies, the studies evaluated are important as model-based health
economic evaluations are today widely accepted as policy-making tools that can inform resource
allocation decisions. Almost half of the model-based studies chose a lifetime perspective and the vast
majority of them applied Markov modelling.
Most trial-based and model-based evaluations in this review applied recommended discount
rates in accordance with the relevant country guidelines. Methods for collecting resource use and
the type of cost included were found to vary across the studies. In particular, the indirect costs of
overweight and obesity (e.g., productivity losses) were not generally collected alongside the trials. It
is considered good practice to report results both with and without indirect costs. Including indirect
costs (e.g., costs incurred by families) has the potential to alter the treatment recommendations.
The narrative synthesis of the economic evidence and the quality assessment of the included
studies are useful for informing health economists/modellers and the direction for future research
in this area. In terms of judging cost-effectiveness of interventions, context-specific assessment is
problematic as there are different thresholds for cost-effectiveness in different countries. For example,
in the UK, NICE recommends a threshold willingness to pay of £20,000–30,000 per QALY [63],
by contrast in Australia the recommendation is AU$50,000 per QALY [29] and in many countries there
are no clearly defined thresholds at all. Whilst most interventions in this review appear cost-effective
using standard rules of cost-effectiveness, there is substantial variation by intervention design.
4.1. Comparison with Previous Systematic Reviews
Our finding that most interventions were cost-effective or even cost-saving, is similar to
those reported by two other reviews [14,18], with some overlap between included studies. Other
reviews have focused on particular age groups (e.g., pre-schoolers [13]), specific interventions
(e.g., only physical activity [17]), or particular outcomes (e.g., anthropometric measurements [13]).
Two additional reviews from Australia [12] and the US [15] used the assessing cost-effectiveness
(ACE) obesity approach to summarise and compare the cost-effectiveness of a range of interventions.
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However, none of the previous studies reviewed the methods of the economic evaluations in the way
we have outlined.
4.2. Strengths and Limitations of this Review
One of the important strengths of this review is the comprehensive search strategy applied
encompassing a broad range of electronic bibliographic databases of published studies and the grey
literature (six additional studies were identified). Furthermore, the results were not limited to only
those published in English (two non-English publications identified) and there were no country
restrictions (there was one publication from china as a developing country), resulting in a more
complete review than those published previously. Also, the formal quality assessment of the economic
evaluations undertaken adds strength to the conclusions. The vast majority of the studies were found
to be of very good reporting quality.
The review had some limitations. As we focused on full economic evaluations, some important
data contained within partial evaluations may have been missed. Further limitations relate to the
shortcomings of the included studies and underlying evidence base. There was heterogeneity in
both the methods used and with the type of intervention being evaluated, which made synthesising
the evidence base challenging. Not all included studies used the same definition of obesity, which
may impact on the results. Most of the included studies reported an economic evaluation for an
intervention that had previously been reported as clinically effective. It is possible that any trial which
had ineffective results did not conduct an economic evaluation or, if they did, failed to get it published,
introducing potential publication bias.
5. Conclusions
This systematic review suggests that current economic evaluations are mainly set in developed
countries and the majority focus on the prevention of obesity in children, compared to treatment.
Our findings show that the majority of published economic evaluations are for interventions
with an individual behaviour change component. The majority, particularly ‘behavioural and
policy’ preventive interventions, were cost-effective, even cost-saving. However the review found
heterogeneity with respect to methods applied. So, to improve the evidence base further and to enhance
comparability across interventions, we recommend a consistent and expanded form of economic
evaluation which captures both health and non-health costs and consequences beyond health-gain.
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